| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 06/20/2013 | US20130158018 Heteroaryl Nitrile Compounds Useful as Inhibitors of Cathepsin-S |
| 06/20/2013 | US20130158011 Novel compounds |
| 06/20/2013 | US20130158006 Aminopyrimidine derivatives as lrrk2 modulators |
| 06/20/2013 | US20130158005 Pyrimidine derivatives as fak inhibitors |
| 06/20/2013 | US20130158004 Azetidine Derivatives |
| 06/20/2013 | US20130158003 Heteroaryl compounds and methods of use thereof |
| 06/20/2013 | US20130157997 Benzimidazole analogues for the treatment or prevention of flavivirus infections |
| 06/20/2013 | US20130157981 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
| 06/20/2013 | US20130157298 2-(2-Hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-Carboxamidine Derivatives as Factor VIIA Inhibitors |
| 06/20/2013 | US20130156761 Compounds Useful for Inhibiting Metastasis from Cancer and Methods Using Same |
| 06/20/2013 | US20130156731 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseas |
| 06/20/2013 | US20130156700 Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (pet) imaging for lrrk2 |
| 06/20/2013 | US20130156699 Radiolabeled compounds and uses thereof |
| 06/20/2013 | US20130153863 Electron transport material and organic light emitting device |
| 06/20/2013 | CA2857197A1 Novel glp-1 receptor modulators |
| 06/19/2013 | EP2604610A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof |
| 06/19/2013 | EP2604603A1 Crystal forms of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide and methods for their preparation |
| 06/19/2013 | EP2604602A1 Heteroaryl-pyrazole derivative |
| 06/19/2013 | EP2604600A1 Isatin derivatives and their use in therapy |
| 06/19/2013 | EP2604597A1 Heterocyclic compound and use thereof |
| 06/19/2013 | EP2604595A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 06/19/2013 | EP2603504A1 Hepatitis c virus inhibitors |
| 06/19/2013 | EP2603503A1 Dabigatran etexilate bismesylate salt, solid state forms and process for preparation thereof |
| 06/19/2013 | EP2603502A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 06/19/2013 | EP2603496A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
| 06/19/2013 | EP2603489A2 Method for applying a first metal onto a second metal, an isolator or semiconductor substrate, and the respective binding units |
| 06/19/2013 | EP2603079A1 Positive allosteric modulators of mglur2 |
| 06/19/2013 | CN1950343B Basic amine compound and use thereof |
| 06/19/2013 | CN103168033A Quinazoline compounds as sodium channel blockers |
| 06/19/2013 | CN103168029A Salts and polymorphs of sulfamide ns3 inhibitors |
| 06/19/2013 | CN103159745A Compound used on organic electroluminescent device and organic electroluminescent device |
| 06/19/2013 | CN103159744A Halobenzene cyano pyrazol compound with insecticidal action as well as preparation method and application |
| 06/19/2013 | CN103159743A Small-molecule inhibitor compound capable of simultaneously inhibiting VEGFR (vascular endothelial growth factor receptor) and EGFR (epidermal growth factor receptor) receptor kinase families and preparation method thereof |
| 06/19/2013 | CN103159742A 5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor |
| 06/19/2013 | CN103159741A Preparation and application of novel tyrosine kinase inhibitor |
| 06/19/2013 | CN103159735A Substitutional imidazole kinase inhibitor |
| 06/19/2013 | CN102276585B Preparation method for and medicinal usage of 4-substituted-phenyl-aryl-carboxylate derivatives |
| 06/19/2013 | CN101880276B Substituted diazepan compounds as orexin receptor antagonists |
| 06/19/2013 | CN101754966B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/19/2013 | CN101747322B Pyridazinone derivatives with 1,2,4-triazole schiff base, preparation method and application thereof |
| 06/19/2013 | CN101715448B Therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 06/19/2013 | CN101678214B 芳基醚哒嗪酮衍生物 Aryl ether pyridazinones |
| 06/19/2013 | CN101405259B Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative |
| 06/19/2013 | CN101072759B Triazole compounds that modulate HSP90 activity |
| 06/18/2013 | US8466161 Hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
| 06/18/2013 | US8466156 2-phenyl-4-cyclopropyl-pyrimidine derivatives |
| 06/18/2013 | US8466155 Pyrimidines |
| 06/18/2013 | US8466154 Methods and compositions related to wrapping of dehydrons |
| 06/18/2013 | CA2567506C Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 06/18/2013 | CA2560896C Imidazole compounds |
| 06/18/2013 | CA2554635C Compounds, compositions containing such compounds and methods of treatment of autoimmune diseases using such compounds |
| 06/13/2013 | WO2013086467A1 Benzotriazine oxides as drugs targeting mycobacterium tuberculosis |
| 06/13/2013 | WO2013086229A1 Bicyclic aryl and heteroaryl sodium channel inhibitors |
| 06/13/2013 | WO2013085339A2 Organic light-emitting compound and organic electroluminescent device using same |
| 06/13/2013 | WO2013084130A1 Multicomponent crystalline system of voriconazole with fumaric acid |
| 06/13/2013 | WO2013083604A1 Kinase inhibitors |
| 06/13/2013 | WO2013083591A1 Substituted pyrazoles as mglu5 receptor modulators |
| 06/13/2013 | WO2013083553A1 Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide |
| 06/13/2013 | WO2013083505A1 Oxime ester photoinitiators |
| 06/13/2013 | WO2013083206A1 Derivatives of 4-hydroxy-1,2,3,4-tetrahydronaphtalen-1-yl urea and their use in the treatment of, inter alia, diseases of the respiratory tract |
| 06/13/2013 | WO2013055825A3 Guanidinyl-substituted polyamides useful for treating human papilloma virus |
| 06/13/2013 | WO2012177893A3 Trpm8 antagonists and their use in treatments |
| 06/13/2013 | US20130150578 Novel hypoglycemic compounds |
| 06/13/2013 | US20130150422 Compositions and methods for treatment of cystic fibrosis and diseases associated with aberrant protein cellular processing |
| 06/13/2013 | US20130150398 Indole Derivatives as CRTH2 Receptor Antagonists |
| 06/13/2013 | US20130150374 Arylalkylamine compound and process for preparing the same |
| 06/13/2013 | US20130150372 4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds |
| 06/13/2013 | US20130150369 Benzotriazine Oxides as Drugs Targeting Mycobacterium Tuberculosis |
| 06/13/2013 | US20130150368 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| 06/13/2013 | US20130150358 Theramutein modulators |
| 06/13/2013 | US20130150356 Acyl Piperazine Derivatives as TTX-S Blockers |
| 06/13/2013 | US20130150355 Novel compounds |
| 06/13/2013 | US20130150350 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | US20130150347 Novel compounds |
| 06/13/2013 | US20130150346 Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome |
| 06/13/2013 | US20130150344 Heterocyclic compound |
| 06/13/2013 | US20130150343 Kinase inhibitors |
| 06/13/2013 | US20130150341 Novel compounds |
| 06/13/2013 | US20130150326 Autotaxin inhibitors and uses thereof |
| 06/13/2013 | US20130150325 3-(Fluorovinyl)pyrazoles and their use |
| 06/13/2013 | CA2858447A1 Kinase inhibitors |
| 06/13/2013 | CA2858420A1 Derivatives of 4-hydroxy-1,2,3,4-tetrahydronaphtalen-1-yl urea and their use in the treatment of, inter alia, diseases of the respiratory tract |
| 06/13/2013 | CA2858316A1 Multicomponent crystalline system of voriconazole with fumaric acid |
| 06/13/2013 | CA2856607A1 Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide |
| 06/13/2013 | CA2855351A1 Novel pyrrole derivatives |
| 06/12/2013 | EP2602255A1 Fused heterocyclic ring compound |
| 06/12/2013 | EP2602248A1 Novel pyrrole compounds |
| 06/12/2013 | EP2601189A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein |
| 06/12/2013 | EP2601188A1 Hepatitis c virus inhibitors |
| 06/12/2013 | EP2601187A1 Deuterated tandospirone derivatives as 5-ht1a receptor agonists |
| 06/12/2013 | EP2601185A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 06/12/2013 | EP2600874A1 Pyrimidine compounds that inhibit anaplastic lymphoma kinase |
| 06/12/2013 | CN1943577B Use of (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 06/12/2013 | CN103154018A Ligands for antibody and Fc-fusion protein purification by affinity chromatography |
| 06/12/2013 | CN103153999A Novel compound acting as a cannabinoid receptor-1 inhibitor |
| 06/12/2013 | CN103153988A Anti-viral compounds |
| 06/12/2013 | CN103153987A Solid state forms of a potent HCV inhibitor |
| 06/12/2013 | CN103153986A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/12/2013 | CN103153984A Inhibitors of bruton's tyrosine kinase |